Comparing liposomal bupivacaine and plain bupivacaine for pain management after thoracoscopic surgery
Official title: Comparison of Plasma Concentration And Efficacy Of Liposomal Bupivacaine And Plain Bupivacaine After Intercostal Injections For Pain Management After Thoracoscopy
Run by Milton S. Hershey Medical Center · NCT03737292 · Data updated 2026-11-12
This study is testing whether a newer form of bupivacaine can help manage pain after thoracoscopic surgery better and safely compared to the regular version.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | Milton S. Hershey Medical Center Academic / other |
| Locations | 1 site (Hershey, Pennsylvania) |
| Status | Recruiting |
| Started | April 9, 2019 |
| Main results expected | December 2026 |
| Study ends | December 2026 |
| Registry record updated | June 12, 2026 |
| Trial ID | NCT03737292 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults over 18 years old undergoing minimally invasive thoracic surgeries such as VATS lobectomy or segmentectomy.
✕Probably not a fit
Patients with chronic pain conditions, previous thoracic surgeries, or those unable to communicate pain scores may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the pharmacokinetics of liposomal bupivacaine (Exparel) compared to plain bupivacaine after intercostal injections for pain control during and after thoracoscopic surgeries. It aims to assess plasma concentrations of bupivacaine following the administration of 266 mg of liposomal bupivacaine versus 2 mg/kg of plain bupivacaine, ensuring that levels remain below toxic thresholds. The study also investigates the safety profile of liposomal bupivacaine in this context, as its use in intercostal injections has not been extensively studied. By analyzing these parameters, the research seeks to provide insights into the efficacy and safety of this newer formulation.
Why it matters
Potential benefit: If successful, this study could lead to improved pain management strategies for patients undergoing thoracoscopic surgeries.
How similar studies have gone: While studies on liposomal bupivacaine have shown promise in other surgical contexts, this specific application in thoracoscopic surgery is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1\. Male or female patients over age 18 undergoing minimally invasive thoracic surgeries including but not limited to: 1. VATS wedge resection /segmentectomy 2. VATS lobectomy. 3. Robot assisted thoracoscopic wedge resection/segmentectomy. 4. Robot assisted thoracoscopic lobectomy procedures. Exclusion Criteria: 1. Patients under18 years of age 2. Patients weighing less than 48 kg 3. Pregnant and lactating females will be excluded from the trial 4. Patients preoperatively taking narcotics for chronic pain in proximity to surgical site 5. Patients with previous ipsilateral thoracic surgery 6. Patients undergoing pleurectomy/mechanical pleurodesis. 7. Patients with high likelihood of conversion from thoracoscopic procedure to open thoracotomy as determined by an operating surgeon 8. Patients with pre-existing painful conditions (CRIPS, fibromyalgia, neuropathy) 9. Patients unable to reliably communicate pain scores such as patients with dementia, alterations in mental status 10. Patients with hypersensitivity to local anesthetics and pain medications used in the study 11. Patients with previous thoracic spine surgeries 12. Patients with increased creatinine (over 1.5mg/dl) 13. Patients with liver dysfunction 14. Non-English speaking patients
Where it's running
-
Milton S. Hershey Medical Center
Hershey, Pennsylvania, United States Recruiting
Study contacts
- Principal investigator: Zoulfira Nisnevitch-Savarese, MD — Penn State Hershey College of Medicine
- Study coordinator: Zoulfira Nisnevitch-Savarese, MD
- Email: znisnevitchsavarese@pennstatehealth.psu.edu
- Phone: 717-531-4264
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Levetiracetam Dosing in Critically Ill on CRRT
This study tests how levetiracetam behaves in the bodies of adults on continuous renal replacement therapy to help figure out the best dosing.
-
Trigonelline Monohydrate for NAD+ Metabolism in Healthy Adults
A small study in healthy adults tests whether taking trigonelline monohydrate by mouth for 4 weeks can change NAD+ levels and how the body handles the supplement, compared with NMN and placebo.
-
Low-Volume PENG Block With Dexamethasone After Hip Replacement
This trial tests whether a smaller PENG block with dexamethasone provides similar pain relief but preserves quadriceps strength after hip replacement, compared with the standard-volume PENG block.
-
Analgesia after open inguinal hernia repair using intrathecal morphine or a transversalis fascia plane block
This trial tests whether intrathecal morphine or a ultrasound-guided transversalis fascia plane block can provide better pain relief after open inguinal hernia repair in adults.
-
Cetuximab bioequivalence test in healthy men
This study tests whether a cetuximab injection is bioequivalent to Erbitux in healthy men to see if they behave the same in the body.
-
Single-level vs two-level erector spinae plane block for breast surgery
This study tests whether a single-level ESPB provides similar pain relief to a two-level ESPB for adults undergoing breast surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.